T1	Participants 13 30	multicenter trial
T2	Participants 77 122	resectable locally invasive pancreatic cancer
T3	Participants 1251 1341	Twenty patients were assigned to the resection group and 22 to the radiochemotherapy group
#1	AnnotatorNotes T3	total 42 patients for the trail
T4	Participants 251 256	Japan
